TCL Archive Senate Votes To Kill A 10% Cut For NIH; Less Severe Budget Cuts Still Possible May 26, 1995
TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
TCL Archive As NCI Sets Deadline For B-06 Reanalysis, Fisher Lawyer Says Demand Is Illegal February 3, 1995
